Microbes are everywhere around us, on our skin, in our noses and in our guts, and even in our blood and tissues.
They are usually harmless to exist to balance the immune system. Some are benign: in the human gut bacteria to help digest food, produce vitamins, and move the toxic pathogens. In reality, the human body contains more bacterial cells that the somatic (body) cells.
The mitochondria, energy or produce nuclear in human cells, have their own DNA and are supposed to come from free-living bacteria. The bacteria are highly integrated functions in the human body.
conventional community health is ready to accept some types of bacteria or viruses can in fact be responsible for one of the few forms of cancer such as Kaposi's sarcoma, cancer of the stomach and cervix, but are not willing to recognize that infectious agents may be intimately linked with the development of most other tumors as well.
However, scientific evidence was more than one hundred years that points to a bacterial cause cancer, a pleomorphic (many of them trained), bacteria, mycoplasma related or similar, which was seen in microscopic slides of many tumors.
Since 20 century, the bacterial origin of cancer was considered a mainstream theory, and articles published in Lancet. However, it was later shelved despite a lot of essential evidence.
Over the past century, hundreds of independent researchers have found a link between bacteria and cancer in animals and humans, but its results have been treated as a scientific curiosity and rarely followed by the establishment of general medicine.
However, the theory has not disappeared, and scientists have continued to seek ways to identify and remove suspicious bacteria.
In 1890, German physician and bacteriologist Robert Koch formulated standard criteria used to assess whether a certain bacteria to cause a specific disease.
"Koch's postulates," though not always valid, provide a good reference point for researchers of disease.
Koch's postulates are as follows:
The bacteria are present in all cases of the disease.
Bacteria isolated from the host's disease and increases the pure culture.
specific disease must be repeated when a pure culture of bacteria is inoculated into a healthy susceptible host.
The bacteria must be recoverable from the experimentally infected host.
However, Koch's postulates have limitations, even Koch acknowledged. They can not hold if:
Specific bacteria (such as that which causes leprosy) can not be "grown in pure culture in the laboratory.
Animal test subjects are immune to infection.
In addition, bacteria that are normally harmless can cause illness if:
Acquired additional virulence factors that pathogens.
It makes access to deep tissues by trauma, surgery, one drop, etc.
That infects a patient with a compromised immune system.
Not everyone infected by the bacteria to develop a serious disease, subclinical infection of low quality may be more common than clinically apparent, symptomatic infection.
The different species of pathogens associated with various cancers fit quite well in the Koch's postulates, because they can be isolated from tumors and grown in a petri dish or cell cultures, and they sometimes give tumors when injected into laboratory animals.
However, many also found in lower concentrations in healthy subjects, and it appears that these microbes only cause disease when the host is weakened.
Host immune system limits the amount of damages an infectious agent can cause. For example, infection with H. pylori cause stomach ulcers and stomach cancer, but many people are asymptomatic carriers. Not all women who were infected by HPV develop cancer of the cervix.
Similarly, we should not expect that all other carriers' cancer germs and get sick. Moreover, these bacteria may have the ability to produce disease than cancer, because H. pylori can cause stomach ulcers as well.
History
Probably the first official mention of "cancer microbe" took place December 3, 1890, when William Russell, a pathologist at the School of Medicine, Royal Infirmary of Edinburgh, gave an address to the Pathological Society of London . He described the histopathological findings of "a characteristic organism of cancer" he observed with a microscope tissue sections stained with fuchsin all forms of cancer that he studied, and also some cases of tuberculosis, syphilis and skin infection.
Microbe has been seen both around and within the tissue cells varied in size and barely visible in one and half times that of red blood cells. Russell believes that the large size of some of these bodies, indicative of a yeast or fungal infections.
Russell microbe can provisionally called "blastomycete" (type of fungus), and rounded shapes so-called "magenta plants" because their properties reddish-blue.
Nine years later, in 1899, Russell published a report in The Lancet on "The parasite of cancer" and said that the conclusion of the bacteria suspected of other diseases that cancer has a stone of stumbling "to the idea of a definitive role for the agencies.
Cultures yielded numerous species of bacteria, and bacteria injected animals gave ambiguous results. Later, many scientists concluded that Russell bodies were merely the result of a degeneration of cells.
In 1920 and 1930, the researcher Royal Raymond Rife pioneer in the RF devices used to kill bacteria. Rampant, it was found that certain frequencies of radio waves, was lethal bacteria, but harmless to human tissues. He also invented a new type of microscope, which used monochromatic light, and was accurate enough to see the air viruses by electron microscopy.
Working in a laboratory in La Jolla, in 1930, said Rife success rate of 100 percent in the treatment of cancer. Rampant in the laboratory was closed due to political pressure from the American Medical Association, most of his papers were destroyed, and currently the only known example of a microscope, there are a museum.
Rife discovered radio frequency devices to kill bacteria, were picked up by Hulda Clark, a Canadian researcher who began working in 1960. Clark also said that many other diseases including diabetes, allergies, epilepsy, Crohn's disease, bipolar disorder, schizophrenia, are caused by bacteria and parasites such as liver fluke.
Improved the Rife technology, and invented a small device raidofrequency called "Zapper" that is required to eradicate the bacteria and other parasites from the body. Instructions on how to build the devices are made available to the public, and can be found on the Internet today.
Clark has been harassed by U.S. authorities until he left to establish his cancer clinic in Mexico where, in 2001, the authorities have forbidden to offer alternative treatments for cancer. Like Rife, Clark claimed a very high success rate in treating cancer is almost 100 percent, but no independent analysis of his claims or those of Rife found.
In the 1960s, countered Dr. Virginia Livingston, the scientific establishment by claiming to have found a bacterium that causes cancer, naming him "cryptocides ancestor" which means "hidden killer". She found that the microbe was a symbiotic function inherent in the human body that was responsible for initiating life and healing of tissues and that the microbe was ultimately responsible for any degeneration and death of all life.
When the body of culture was injected into animals, it caused tumors to develop in some but not all, of the test subjects.
In 1974, Livingstone, the first scientist to discover that bacteria and cancer in both cancer cells produce the hormone HCG human. This hormone, normally secreted by the human fetus for protection from the maternal immune system also protects cancer immune attack.
Livingstone concluded that bacteria secrete mutagenic factors such as actinomycin-D cells with human DNA damage, and can exchange genetic material as factors in the growth of bacteria with human cells. Cancer vaccines targeting HCG production and promotion of the bacteria to deprive cancer cells of a key source of HCG .. Since hCG is low, the immune system's ability to launch an assault on the increases in cancer cells.
Livingstone cultivation of bacteria in patients 'own blood and urine to create a "autogenous' vaccines stimulate the immune system. He has published numerous articles and books like" cancer, new initiatives "(1972)," Microbiology of Cancer (1977 ) and "Conquest of Cancer" (1984).
His research has been confirmed by other scientists, such as microbiologist Eleanor Alexander-Jackson, cell cytologist Irene Diller, biochemist Florence Seibert, and dermatologist Alan Cantwell, among others.
Milton Wainwright, a microbiologist at the University of Sheffield, UK, wrote a lot of Bacteriology cancer in recent publications, such as "nanobacteria and" elementary bodies in human disease and cancer "(1999)," the return of germs cancer; Forgotten Microbiology - Back to the Future "(2000)," Highly pleomorphic staphylococci cause cancer "(2000) and" E 'a historical' cancer germ '? "(2003).
Currently, one of the best defenders in the known link between cancer and bacteria is popular Dr. Alan Cantwell, who wrote numerous articles and books on the subject. Cantwell isolated and identified the bacterial cell wall-deficient breast cancer, Kaposi's sarcoma and Hodgkin's disease. He said: "If a disease like cancer is indeed caused by microscopic bacteria will show doctors were unable to see what was obvious to some scientists in the nineteenth and twentieth centuries, to observe the simple light microscope .
And with powerful electron microscopes, there is now little excuse for not "see" bacteria. "
Mycoplasma
Mycoplasma, the oldest of the suspected bacterial theory of cancer, was also involved as a direct cause or a signficant cofactoer and many other degenerative and inflammatory diseases.
Mycoplasmas are often found in the oral and urogenital tracts of healthy subjects, with females four times more often infected than men, which happens to be the same gender-skewed incidence of rheumatoid arthritis, fibromyalgia, chronic fatigue syndrome and other autoimmune diseases.
In 1997, the National Center for Infectious Diseases, Centers for Disease Control and Prevention's journal, Emerging Infectious Diseases, published the article, Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety, by Drs. Base and Tully who stated:
"However, mycoplasmas, in itself can cause acute and chronic diseases are more sites where the vast complications and has been involved as cofactors of the disease.
Recently, mycoplasmas have been linked as a cofactor in the pathogenesis of AIDS and malignant transformation, chromosomal aberrations, the Gulf War syndrome and other unexplained illnesses and complex, including chronic fatigue syndrome, Crohn's disease and various arthritides. "
The first strains of mycoplasma have been isolated from cattle with arthritis and pleuro-pneumonia in 1898 at the Institut Pasteur. The first black man was isolated in 1932 from an abscess of the wound.
First Contact mycoplasmas have been found to cause rheumatic diseases in 1939, Drs. Swift and Brown. At the end of 1950, a specific location has been found to cause atypical pneumonia, and named Mycoplasma pneumonia.
The association between immune deficiency and immune disorders, and mycoplasmas were found for the first time in mid-1970 in patients with primary hypogammaglobulinemia (an autoimmune disease) due to infection of four species of mycoplasma localized in joint tissue.
Since then, more than 100 different species of mycoplasma have been identified and recorded on plants, animals and humans.
There are hundreds of scientific studies from around the world among different species of mycoplasma by cancer.
Research by Dr. Shy-Chung Lo Institute of Pathology Armed Forces in Washington, DC, confirms the multi-stage malignant transformation of embryonic cell lines continuously exposed to mycoplasma infection, animal models and exposed.
According to a study by Chan PJ, published in Gynecologic Oncology (1996), "The oncogenic potential of mycoplasmas has been achieved recently when they were shown to cause chromosomal aberrations and cell transformation in vitro by the gradual and progressive loss of chromosome transfer ". Chan and colleagues also report the prevalence of Mycoplasma DNA in the ovary cancer.1
In 1993, a research team led by C. Ilantzis McGill Cancer Centre, Montreal, Canada analyzed markers associated with cancer that are specific to different body organs. These markers, called "organ-specific neoantigens (OSN), causes a specific immune response. After the analysis of proteins NSOs human colon adenocarcinoma, the researchers found mycoplasma in OSN origin2
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Chan PJ, et al Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA pp 258-260 Gynecologic Oncology 1996 (3)
(2). C Ilantzis, DM, Thomson, Michaelidou, S Benchimol Identification of human cancer related organ-specific neoantigen Microbiol Immunol, 1993, 37 (2) :119-28
Microscopic evaluation
The "cancer bacteria" has a variable appearance in both tissue samples and cultures. They may appear as shells (circles) 0.1 microns (one micron equals one thousandth of a millimeter), called "submicroscopic" because they can still be seen by an ordinary light microscope.
The researchers used the term "nanobacteria" to describe the very small bacteria, ranging from 0.05 to 0.2 microns in size. The virus, which measures 0.01 to 0.02 micrometers, can only be viewed under the electron microscope. The smallest bacteria can easily pass through the pores of the filter standard virus 0 0.2 micrometres, which microbiologists assumed (until recently) would reach all the bacteria, which tend to be much higher.
When these young leaders are placed in a petri dish and the resulting culture was observed over time, bacteria also produce large stems and branched fungal-like filaments.
Mycobacteria are known in different formats, and TB microbe, Mycobacterium tuberculosis, is a good example of this complex life cycle. Some forms of Bacillus is round "coccoid" forms, other forms are typically "acid-fast" and "real" forms. All mycobacteria are phylogenetically link or bridge for the bacteria and the "higher" fungi. "MyCo" in greek mushroom. This is the term "noise". Mycoplasma is also flowing into the plasma as in the structure without a cell wall - that is, "plasma".
Contrary to common bacteria, which are suspected cancer microbe Mycoplasma no cell wall. It penetrates the cells of tissues and cells to be repeated, as well as anti-retroviral drugs. When an outbreak of Mycoplasma cell, takes a piece with the host cell membrane. When the immune system attacks the Mycoplasma, may also mistakenly attack the host cell, causing an autoimmune condition. You can attack the natural killer cells are the immune system, which causes immune system disorders. Why can hide deep in the cells, it is very difficult to detect and remove.
Antibiotics for the treatment of Mycoplasma
Antibiotic treatment should be tailored to bacterial infections. Many bacteria, including mycoplasma, do not affect many common antibiotics. However, some targeted therapies, which are known to kill specific bacteria that cause cancer have proved effective, at least in the early stages of the disease.
Mycoplasma treatable with long cycles of high doses of antibiotics such as doxycycline and tetracycline, followed by a long period of low dose antibiotics. Because of their lack of cell wall, mycoplasmas are resistant to penicillins. Since the organism is slow growing, intracellular species with a long shelf life, over the longer term antibiotics may be needed. The infection may require treatment for several months or years, virtually the same protocol as for Lyme disease.
No clinical studies have been published on cancer treatment with antibiotics against mycoplasma.
Vaccines against Mycoplasma
Maruyama vaccine like BCG, who are both due to mycobacteria tuberculosis isolates. Both have been widely used as a stimulant of the immune system in cancer patients. Murayama vaccine is made from mycobacteria tuberculosis isolates, and BCG is derived from a bacillus of bovine tuberculosis attenuated. However, BCG has more side effects than the vaccine Maruyama.
Maruyama vaccine, invented by Dr. Chisato Maruyama more than 50 years may be used alone or in combination with standard treatments. Some Japanese doctors claim to have achieved complete remission for poor prognosis cancers, but no large clinical trial exist. No adverse effects of the vaccine have been reported.
Murayama vaccine approved by the FDA for the treatment of patients with terminal cancer. Some forms of medical insurance covers the cost if the vaccine is used as part of standard therapy, as it is officially approved only as an immune stimulant to counteract the side effects of bone marrow depression caused by radiotherapy.
Maruyama vaccine issued by the Research Institute of vaccine therapy for tumors and infectious diseases, Nippon Medical School Hospital in Tokyo, as long as the patient provide a request from their doctor. It is not expensive, about 9,000 yen (100 USD) for a treatment of 40 days.
According to an article published in the detection and prevention of cancer, 2003, Tetsuo Kimoto MD, Ph.D., Maruyama vaccine does not have direct cytotoxic effects on tumors, but the reasons for their homes and collagen.
This leads to necrosis of contention and sometimes (death) of tumors and their metastases. The survival time has increased in both animals and humans with tumors, and Kimoto Murayama said that the vaccination "can benefit patients whose tumors are inoperable and resistant to conventional chemotherapy." 1
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Tetsuo Kimoto MD, Ph.D. antitumor effects of Maruyama vaccine (SSM), the detection and cancer prevention Volume 22 Issue 4 Page 340 - August 1998.
Herpes Virus
Cervical cancer, caused by human papilloma virus, affects more than 10,000 U.S. women each year, killing more than 3,700. A new vaccine against the virus, Gardasil was approved by the FDA in 2006. The vaccine is effective against HPV types 16 and 18 cause about 70 percent of cervical cancers and HPV types 6 and 11 cause 90 percent of genital warts.
Less known is the fact that HPV is also implicated in squamous cell head and neck, especially cancer of the tonsils. 1.2 Researchers from Johns Hopkins Oncology Center tested tumor tissue from 253 patients with carcinoma of the head and neck and found 25 per cent of cases were positive for HPV. In 90 percent of HPV-positive tumors, HPV16, the type of virus most often associated with cervical present.3
Several studies confirm the link between HPV and head and neck cancer. Approximately 31,000 people in the United States are diagnosed annually with cancer of the oral cavity and pharynx, causing 8,500 deaths a year.
The HPV vaccine works only if administered before infection, indicating the importance of immunization before potential exposure to the virus. Also, Gardasil does not protect against less common HPV types not included in the vaccine, thus routine and regular pap screening remain vitally important to detect precancerous changes in the cervix to allow treatment before cervical cancer develops. This is a preventive measure, not a treatment for cancer of the cervix existing or head and neck.
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Paz IB, et al. Human Papillomavirus (HPV) in head and neck. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer February 1, 1997, 79 (3) :595-604.
(2) Klussman JP et al, HPV positive tonsillar carcinomas:. Another tumor entity? With Immunol Microbiol (Berlin) in August 2003, 192 (3) :129-32. Epub 2002 September 14.
(3). Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, symer DE, Shah KV, Sidransky D, proof of a causal link between human papillomavirus and a subset of head and neck cancer. Magazine National Cancer Institute. 2000 if 3 92 (9) :709-20
Stomach cancer
In December 2000 edition of the Journal of the National Cancer Institute, a research team led by British pathologist Pelayo Correa said that antibiotics, vitamin C or beta-carotene (precursor of vitamin A) can reverse stomach precancerous conditions caused by Helicobacter pylori.
Stomach cancer is the second most common cancer worldwide, and is more common in countries like Colombia and China, where H. pylori infects over half the population in early childhood. United States, where H. pylori is less common, rates of stomach cancer has decreased since the 1930's.
The two main risk factors for stomach cancer is infection with H. pylori, and a diet low in vitamin C and beta-carotene, which the body converts to vitamin A. There is also ample evidence that a diet containing fruits and vegetables that are rich in these nutrients, protects against stomach cancer.
In 1992, researchers studied 631 patients with full stomach cell growth, which is one of three consecutive steps precancerous - nonmetaplastic multifocal atrophy, intestinal metaplasia and dysplasia.
The patients received a placebo pill, vitamin C or beta-carotene supplements or antibiotics against H. pylori. Others were a combination of drugs and supplements.
Researchers found gastric biopsies of patients after 3 and 6 years of treatment. Patients with atrophy were about five times more likely to experience regression of the growth of precancerous cells that achieve a placebo.
Among those with metaplasia, the volunteers taking supplements or drugs were three times more likely to improve as the placebos were. However, patients with dysplasia, the last stage of the disease of the stomach before the cancer did not show significant improvement with treatment. "The earlier in the process [who intervened] the better the chance of regression," Correa said. 1
This study is encouraging because it shows that the treatment of cancer-causing bacteria, provides clear benefits against precancerous conditions. However, when tissue damage caused by the infection had developed in the precancerous stage, the antibiotics produced no benefits, and would probably produce no improvement in cases of outright malignancy, either.
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Correa, P., et al. The 2000th Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori treatment. National Cancer Institute Magazine 92 (December 6) :1881-1888
Lymphoma
The common antibiotic doxycycline effectively treats a type of ocular lymphoma associated with chlamydia, according to a study published in the October 4 issue of the Journal of the National Cancer Institute.
A team of researchers led by Andres JM Ferreri, MD, San Raffaele H Scientific Institute in Milan, Italy, gave 27 patients with ocular adnexal lymphoma (OAL) a course of 3 weeks of doxycycline treatment, whether positive or negative for chlamydia.
The researchers looked at tumor progression every 6 months, and found that doxycycline caused a regression caused lymphoma in patients regardless of whether they were positive or negative for chlamydia.
The study suggests that doxycycline is a useful therapy even in patients where other treatments have failed, and it is a real alternative to chemotherapy and radiation without causing the same toxic side effects. Patients treated with doxycycline had a rate of 66% disease-free survival. 1
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Andrés JM Ferreri, Maurilio Ponzoni, Massimo Guidoboni, reimbursement rates Antonio Giordano, Letterio S. Politi Sergio Cortelazzo, Judit Demeter, Francesco Zallio, Angelo Palmas, Giuliana Muti, Giuseppina P. Dognin, Elisa Pasini, Antonia Anna Lettini, Federico Sacchetti, Carlo The Conciliis, Claudio Doglioni, Riccardo Dolcetti Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A prospective multicenter trial Journal of the National Cancer Institute 2006 98 ( 19) :1375-1382
Caution regarding the use of antibiotics
So far, no antibiotic treatment has been observed that successful treatment of most cancers, and research combining the use of antibiotics are at increased risk of breast cancer was published in February 2004, Journal of American Medical Association. A survey of 10 000 women in the State of Washington, found that those who took more than 25 courses of antibiotics over an average of 17 years had double the risk of developing breast cancer than women who are not antibiotics. The women who took one and 25 prescriptions over the same period was one and a half times higher risk of developing breast cancer. 1
Correlation does not always mean causation, and this study raises interesting questions regarding the mechanism of this effect. Perhaps this is due to direct cellular damage caused by antibiotics. Perhaps the disruption of normal homeostasis of bacteria to antibiotics leads to the proliferation of pathogenic bacterial species.
It could be that women with poorly functioning immune system (due to genetics or poor living conditions) are more prone to infections and cancer. A need for antibiotics may indicate underlying disease or inflammatory diseases, which is responsible for the development of cancer.
However, the study illustrates the dangers of using broad-spectrum antibiotics indiscriminately. This practice is clearly not to prevent cancer, and is not recommended.
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Roberta B. Ness, MD, MPH. Jane A. Cauley, antibiotics and breast cancer DrPH -. What is the meaning of this? 291:77 February Journal American Medical Association 2004, 880-881
Antibiotics to treat cancer
In 2006, researchers have discovered at the University of Illinois at siomycin, an unknown reality first antibiotic discovered in 1960, caused cancer cells to apoptosis (cell death), while normal cells unharmed. This is due to a direct effect on FOX M1 gene that is activated in tumor cells and causes their rapid growth. Siomycin being evaluated for possible clinical studies. 1
Neomycin, another former first antibiotic discovered in 1949, inhibits angiogenesis (blood vessel development) of prostate tumors and prevents them from growing and spreading in animal subjects, according to researchers and Yoshioka Hu in September 2006 work of the National Academy of Sciences. 2
In both cases, the activity of these antibiotics is a direct effect of chemotherapy, no antibacterial activity. However, both these substances promising developments in chemotherapy, without the side effects current horrendous.
-------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------
(1). Senthil K. Radhakrishnan, G. Uppoor Bhat, Douglas E. Hughes, I-Ching Wang, Robert H. Costa, and Andrei L. Gartel Identification of Chemical inhibitor of oncogenic transcription factor forkhead Box M1 Cancer Research 66, 9731-9735, October 1, 2006
(2). Hu GF. Neomycin inhibits angiogenin-induced angiogenesis. Proc. Natl. Acad. Science. U.S. 95: 9791-9795, 1998
Integrated Treatment Clinics
Livingstone, said Wheeler, a success rate of 82% in his book "The conquest of cancer."
One of the largest clinics offering treatment based on the hypothesis of cancer is the bacterial Livingstone Wheeler Foundation Medical Center, San Diego, California. Livingstone, said Wheeler, a success rate of 82% in his book "The conquest of cancer." Here, patients receive vaccines and other measures to strengthen the immunity of pleomorphic bacteria believed to cause cancer.
The BCG vaccine is used with a treatment program multifocal: vegetarian diet, vitamins, antioxidants, detoxification, nutritional counseling, support groups. Patients followed by tests of immune function and vitamin levels.
However, in 2001 the study of the Centre for Alternative Medicine Research at the University of Texas found the poor performance of the clinic of 191 patients were followed for about half of them had metastatic cancer. Only 28 of 193 patients were found still alive five years later, when the five-year survival rate was 14.5%, no better than conventional therapy with advanced cancer. These results contradict the statements of Livingstone success.
However, other professionals have had better results. Issels Clinic, founded in 1951 in Germany by Dr. Josef Issels, specializing in immunotherapy (with other alternative treatments) and already has a significant success rate documented by independent studies.
Since the end of 1960, the German health insurance covered the treatment Issels Clinic. From 1981 until his retirement in 1987, Dr. Issels served as an expert of the German Government Commission, the fight against cancer.
In clinical trials, Journal (London 1970) peer-reviewed research has shown that the Issels treatment and conventional therapy (chemotherapy and radiotherapy) has improved by a five-year survival rate for patients with metastatic tumors to 87%, compared 50% with standard therapy alone.
In 1959, AG Audier, MD, University of Leiden, the Netherlands, reported that the Issels treatment produces a cure rate of 16.6% in 252 patients with metastatic melanoma, which only has a cure rate at 2% conventional treatments.
This was confirmed by a study conducted in 1971 by John Anderson, MD, of King's College Hospital, which showed a cure rate of 17% for metastatic melanoma. Issels clinic has documented long-term cure (> 10 years) of advanced metastatic cancer, including astrocytomas (malignant tumors of the brain) and melanomas, which are virtually incurable with conventional therapy.
There are two medical clinics in the United States Issels in Phoenix, Arizona, and Santa Barbara, California.
Summary
The proof of a causal link between infection and cancer seems to be overwhelming, but so far there is no universal treatment has been developed with this information.
In some cases, such as intraocular lymphoma, eradication of the infection heals cancer, but in other cases, such as gastric cancer, it has no effect when the disease has evolved from pre- malignant cancer. So far, some success with immunotherapy, but be sure to look for a reputable clinic with proven results, that patient outcomes vary widely among practitioners.
This is certainly an area to watch closely, as new discoveries are made constantly.
